Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.523
+0.003 (0.60%)
At close: Dec 5, 2025
Elite Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 26.62 | 11.32 | 7.11 | 7.83 | 8.54 | 3.19 | Upgrade
|
| Cash & Short-Term Investments | 26.62 | 11.32 | 7.11 | 7.83 | 8.54 | 3.19 | Upgrade
|
| Cash Growth | 178.57% | 59.23% | -9.27% | -8.24% | 167.33% | 182.11% | Upgrade
|
| Receivables | 40.87 | 29.21 | 19.45 | 3.09 | 3.06 | 3.5 | Upgrade
|
| Inventory | 18.16 | 16.24 | 12.93 | 9.55 | 6.74 | 5.01 | Upgrade
|
| Prepaid Expenses | 0.14 | 0.98 | 0.52 | 1.03 | 0.53 | 0.49 | Upgrade
|
| Total Current Assets | 85.79 | 57.74 | 40.01 | 21.51 | 18.86 | 12.19 | Upgrade
|
| Property, Plant & Equipment | 13.4 | 14.1 | 14.61 | 10.44 | 6.98 | 6.86 | Upgrade
|
| Other Intangible Assets | 0.29 | 0.29 | 0.29 | 0.29 | 0.47 | 0.47 | Upgrade
|
| Long-Term Deferred Tax Assets | 11.8 | 18.37 | 22.16 | 2.17 | 2.17 | - | Upgrade
|
| Long-Term Deferred Charges | 5.35 | 5.35 | 6.05 | 6.05 | 6.17 | 6.17 | Upgrade
|
| Other Long-Term Assets | 0.61 | 0.55 | 0.53 | 0.43 | 0.5 | 0.5 | Upgrade
|
| Total Assets | 117.25 | 96.39 | 83.65 | 40.9 | 35.15 | 26.19 | Upgrade
|
| Accounts Payable | 3.42 | 2.96 | 2.71 | 2.45 | 1.43 | 0.93 | Upgrade
|
| Accrued Expenses | 5.88 | 3.45 | 4.82 | 4.63 | 4.28 | 4.27 | Upgrade
|
| Short-Term Debt | - | 4 | 4 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.23 | 0.25 | 0.3 | 0.31 | 0.35 | 0.41 | Upgrade
|
| Current Portion of Leases | 0.87 | 0.84 | 0.72 | 0.01 | 0.2 | 0.19 | Upgrade
|
| Current Income Taxes Payable | 0.27 | 0.34 | 0.49 | 0.41 | 0.41 | - | Upgrade
|
| Current Unearned Revenue | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Current Liabilities | 10.67 | 11.84 | 13.05 | 7.83 | 6.69 | 5.81 | Upgrade
|
| Long-Term Debt | 2.84 | 3.03 | 3.28 | 3.56 | 1.39 | 1.74 | Upgrade
|
| Long-Term Leases | 2.36 | 2.8 | 3.44 | - | 0.84 | 0.04 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 0.01 | 0.02 | 0.03 | 0.05 | Upgrade
|
| Other Long-Term Liabilities | 39.79 | 25.2 | 6.3 | 0.52 | 0.98 | 2.4 | Upgrade
|
| Total Liabilities | 55.66 | 42.87 | 26.07 | 11.94 | 9.93 | 10.04 | Upgrade
|
| Common Stock | 1.07 | 1.07 | 1.07 | 1.01 | 1.01 | 1.01 | Upgrade
|
| Additional Paid-In Capital | 173.7 | 173.46 | 173.21 | 164.75 | 164.58 | 164.41 | Upgrade
|
| Retained Earnings | -112.89 | -120.7 | -116.39 | -136.5 | -140.06 | -148.96 | Upgrade
|
| Treasury Stock | -0.31 | -0.31 | -0.31 | -0.31 | -0.31 | -0.31 | Upgrade
|
| Total Common Equity | 61.58 | 53.52 | 57.58 | 28.96 | 25.22 | 16.15 | Upgrade
|
| Shareholders' Equity | 61.58 | 53.52 | 57.58 | 28.96 | 25.22 | 16.15 | Upgrade
|
| Total Liabilities & Equity | 117.25 | 96.39 | 83.65 | 40.9 | 35.15 | 26.19 | Upgrade
|
| Total Debt | 6.3 | 10.91 | 11.74 | 3.89 | 2.78 | 2.38 | Upgrade
|
| Net Cash (Debt) | 20.32 | 0.4 | -4.63 | 3.94 | 5.75 | 0.81 | Upgrade
|
| Net Cash Growth | - | - | - | -31.44% | 606.63% | - | Upgrade
|
| Net Cash Per Share | 0.02 | 0.00 | -0.00 | 0.00 | 0.01 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 1,074 | 1,068 | 1,068 | 1,014 | 1,011 | 1,009 | Upgrade
|
| Total Common Shares Outstanding | 1,073 | 1,068 | 1,068 | 1,014 | 1,011 | 1,009 | Upgrade
|
| Working Capital | 75.12 | 45.9 | 26.96 | 13.68 | 12.17 | 6.38 | Upgrade
|
| Book Value Per Share | 0.06 | 0.05 | 0.05 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Tangible Book Value | 61.3 | 53.23 | 57.29 | 28.67 | 24.76 | 15.69 | Upgrade
|
| Tangible Book Value Per Share | 0.06 | 0.05 | 0.05 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Land | 11.65 | 11.65 | 11.06 | 10.77 | 5.46 | 5.46 | Upgrade
|
| Machinery | 16.03 | 15.71 | 15.02 | 14.24 | 13.85 | 13.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.